GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Cash Ratio

Abbott India (BOM:500488) Cash Ratio : 1.66 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Abbott India's Cash Ratio for the quarter that ended in Mar. 2024 was 1.66.

Abbott India has a Cash Ratio of 1.66. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Abbott India's Cash Ratio or its related term are showing as below:

BOM:500488' s Cash Ratio Range Over the Past 10 Years
Min: 1.53   Med: 1.99   Max: 2.46
Current: 1.66

During the past 13 years, Abbott India's highest Cash Ratio was 2.46. The lowest was 1.53. And the median was 1.99.

BOM:500488's Cash Ratio is ranked better than
74.76% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:500488: 1.66

Abbott India Cash Ratio Historical Data

The historical data trend for Abbott India's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Cash Ratio Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.46 2.33 2.27 1.59 1.66

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 - 1.62 - 1.66

Competitive Comparison of Abbott India's Cash Ratio

For the Drug Manufacturers - General subindustry, Abbott India's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Cash Ratio falls into.



Abbott India Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Abbott India's Cash Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash Ratio (A: Mar. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=22290.5/13427.2
=1.66

Abbott India's Cash Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash Ratio (Q: Mar. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=22290.5/13427.2
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (BOM:500488) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Abbott India Cash Ratio Related Terms

Thank you for viewing the detailed overview of Abbott India's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines